Turnstone Biologics
(NASDAQ) TSBX
Turnstone Biologics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.02M
Net Income (TTM)
$47.20M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
TSBX News
TSBX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Turnstone Biologics
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
Sammy J. Farah, PhD, MBA
Website
turnstonebio.comHeadquarters
LA Jolla, CA 92037, US
TSBX Financials
Key Financial Metrics (TTM)
Gross Margin
10%
Operating Margin
-22%
Net Income Margin
-23%
Return on Equity
-2%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.83M
Operating Income
$72.49M
EBITDA
$68.97M
Operating Cash Flow
$67.44M
Capital Expenditure
$229.00K
Free Cash Flow
$67.67M
Cash & ST Invst.
$28.93M
Total Debt
$1.19M
Turnstone Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
14
N/A
Net Income
$5.49M
+74.2%
EBITDA
$5.56M
+74.2%
Quarterly Fundamentals
Net Cash
$16.28M
-73.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$411.00K
-88.5%
Return on Assets
-2.24%
N/A
Return on Invested Capital
-3.01%
N/A
Free Cash Flow
$4.30M
+73.3%
Operating Cash Flow
$4.30M
+73.1%